Application of Single-Use Technologies (SUT) in Biosimilar Development Kumar Jeetendra | July 4, 2022 The current processing paradigm of large manufacturing facilities dedicated to single-product production is no longer an effective approach for best manufacturing practices. Additionally, in recent years, patents on several blockbuster biologics have expired, which means leading pharmaceutical companies can no longer charge a premium for these products. The subsequent launch of biosimilar drugs, which can …
